StockWatch
·
Pharmaceuticals
Board Meeting13 Aug 2026, 08:03 pm

Brooks Laboratories Ltd Board Approves Unaudited Financial Results for Q1 FY27

AI Summary

Brooks Laboratories Ltd announced that its Board of Directors, in a meeting held on August 13, 2026, considered and approved the unaudited financial results for the quarter ended June 30, 2026. The company also received a Limited Review Report from its independent auditor, DM KH & Co. The results, prepared in accordance with Ind AS 34, were found to be free of material misstatements. The board meeting commenced at 4:00 PM and concluded at 6:00 PM. Further details will be available on the company's website.

Key Highlights

  • Board approved unaudited financial results for Q1 FY27.
  • Limited Review Report received from independent auditor.
  • Results prepared as per Ind AS 34 accounting standards.
  • No material misstatements identified in the financial results.
  • Information to be hosted on the company's website.